United Kingdom· GB-APID-40953511000001105
Atgam 250mg/5ml concentrate for solution for infusion ampoules
A medicinal product containing anti-human t lymphocyte immunoglobulin (equine), registered in United Kingdom by Pfizer Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Anti-human T lymphocyte immunoglobulin (equine)
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5013457010930
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eae20b66-b737-4af9-aae8-f2ee84f0e61c GET /v1/drugs/eae20b66-b737-4af9-aae8-f2ee84f0e61c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40953511000001105",
"desc": "Atgam 250mg/5ml concentrate for solution for infusion ampoules (Pfizer Ltd)",
"form": "Solution for infusion",
"vpid": "32149811000001100",
"source": "dmd",
"vtm_id": "10984011000001106",
"strength": "50 mg",
"substance": "Anti-human T lymphocyte immunoglobulin (equine)",
"ingredient": "Anti-human T lymphocyte immunoglobulin (equine)",
"supplier_code": "2082201000001106"
}See everything about anti-human t lymphocyte immunoglobulin (equine).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.